UNITED THERAPEUTICS AND LEE’S PHARMACEUTICAL SIGN REMODULIN DISTRIBUTION AGREEMENT FOR CHINA 2010.07.02

 
Silver Spring, MD, June 30, 2010: United Therapeutics Corporation (NASDAQ: UTHR) and Lee’s Pharmaceutical Holdings Ltd (HKEx: 0950) announced today that they have entered into an exclusive agreement for the distribution of Remodulin (treprostinil) Injection in China. Remodulin is a subcutaneously or intravenously administered prostacyclin analogue for the treatment of pulmonary arterial hypertension. Lee’s Pharmaceutical is a leading Chinese pharmaceutical company with both a strong cardiovascular focus and extensive commercialization experience.
 
  Download  


© Lee's Pharmaceutical Holdings Limited     Terms of Use   |   Privacy Statement Designed by YSD